title: Favourable response to rituximab by an ocular adnexal primary lymphoma.
abstract: METHODS
  A 70-year-old woman who presented with an extranodal marginal zone B-cell lymphoma in lacrimal gland and conjunctiva. Initial treatment with rituximab yielded an immediate good response. Five months later she showed lymphoid proliferation in her contralateral conjunctiva. Although no additional treatment was performed, the patient has been free of systemic symptoms and recurrences.
  
  
  CONCLUSIONS
  Rituximab is a quite good therapeutic agent in low grade adnexal lymphomas.
authors.affiliation: Sección de Oftalmología, Hospital El Escorial, San Lorenzo de El Escorial, Madrid, España. Electronic address: marisa.luque@yahoo.es.
authors.forename: M L
authors.initials: ML
authors.lastname: Luque Valentin-Fernandez
authors.affiliation: Servicio de Anatomía Patológica, Hospital Universitario Infanta Leonor, Madrid, España.
authors.forename: F
authors.initials: F
authors.lastname: Alvarez Rodríguez
authors.affiliation: Servicio de Radiodiagnóstico, Hospital Universitario El Escorial, San Lorenzo de El Escorial, Madrid, España.
authors.forename: I
authors.initials: I
authors.lastname: Rodríguez Jiménez
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003230:Conjunctival Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007766:Lacrimal Apparatus Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy*; D018442:Lymphoma, B-Cell, Marginal Zone / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008279:Magnetic Resonance Imaging; D012074:Remission Induction; D000069283:Rituximab / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D000069283:Rituximab
keywords: Conjunctival lymphoma; Lacrimal gland lymphoma; Linfoma; Linfoma de anejos oculares; Linfoma de conjuntiva; Linfoma de glándula lagrimal; Lymphoma; Ocular adnexal lymphoma; Rituximab